Today's Information |
Provided by: SYNMOSA BIOPHARMA CORPORATION | |||||
SEQ_NO | 1 | Date of announcement | 2022/08/11 | Time of announcement | 15:54:09 |
Subject | To announces SYNMOSA board of directors has lifted the restriction on the prohibition of competition for managerial officer | ||||
Date of events | 2022/08/11 | To which item it meets | paragraph 21 | ||
Statement | 1.Date of the board of directors resolution:2022/08/11 2.Name and title of the managerial officer with permission to engage in competitive conduct: Lin, Chih-Hui/General Manager 3.Items of competitive conduct in which the officer is permitted to engage: Serving as a managerial officer、director or supervisor of a company with the same or similar business scope as the company. 4.Period of permission to engage in the competitive conduct: Managerial officer while working as a supervisor of the company. 5.Circumstances of the resolution (please describe the results of voting in accordance with Article 32 of the Company Act): All directors passed without objection. 6.If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the managerial officer (if it is not the operator of a mainland China enterprise, please enter "N/A" below):N/A 7.Company name of the mainland China enterprise and the officer's position in the enterprise:N/A 8.Address of the mainland China enterprise:N/A 9.Operations of the mainland China enterprise:N/A 10.Impact on the company's finance and business:none 11.If the managerial officer or director has invested in the mainland China enterprise, the monetary amount of the investment and the officer or director's shareholding ratio:none 12.Any other matters that need to be specified:none |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Synmosa Biopharma Corporation published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 08:00:00 UTC.